UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices and zip code)
(441 ) 298-4900
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading symbol(s) | Name of Each Exchange on Which Registered | ||||||||||||
| Item 2.02 | Results of Operations and Financial Condition. | ||||
On March 14, 2022, the Company issued a press release announcing its results of operations for the three and twelve months ended December 31, 2021. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information contained in this Item 2.02 and in the accompanying exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
| Item 7.01 | Regulation FD. | ||||
On March 14, 2022 , the Company posted its March 2022 Investor Presentation via its investor relations website at https://www.maiden.bm/investor_relations, which presentation is included as Exhibit 99.3 to this Current Report on Form 8-K.
The information under Item 7.01 and the Investor Presentation included to this Form 8-K as Exhibit 99.3 shall be deemed to be “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act. The furnishing of the information in this report is not intended to, and does not, constitute a determination or admission by the Company that the information in this report is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company.
| Item 8.01 | Other Events. | ||||
On March 14, 2022, the Company issued a press release announcing its results of operations for the three and twelve months ended December 31, 2021 via its investor relations website at https://www.maiden.bm/investor_relations, which press release is included as Exhibit 99.2 to this Current Report on Form 8-K and incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits. | ||||
(d) Exhibit
| Exhibit | ||||||||
| No. | Description | |||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
| 99.3 | ||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: | March 14, 2022 | MAIDEN HOLDINGS, LTD. | |||||||||
| By: | /s/ Lawrence F. Metz | ||||||||||
| Lawrence F. Metz | |||||||||||
| President and Co-Chief Executive Officer | |||||||||||
EXHIBIT INDEX
| Exhibit | ||||||||
| No. | Description | |||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
| 99.3 | ||||||||
Exhibit 99.1
PRESS RELEASE
Maiden Holdings, Ltd. Announces
Fourth Quarter and Year End 2021 Financial Results
PEMBROKE, Bermuda, March 14, 2022 - Maiden Holdings, Ltd. (NASDAQ: MHLD) ("Maiden" or the "Company") today reported fourth quarter 2021 net income available to Maiden common shareholders of $16.2 million or $0.19 per diluted common share compared to $47.7 million or $0.56 per diluted common share in the fourth quarter of 2020.
Non-GAAP operating earnings(5) were $2.3 million or $0.03 per diluted common share for the fourth quarter of 2021 compared to $45.0 million or $0.53 per diluted common share for the same period in 2020.
Maiden's book value per common share(1) was $2.60 at December 31, 2021 compared to $1.57 at December 31, 2020. On a non-GAAP basis, adjusted for unamortized deferred gain on ceded retroactive reinsurance recognized as of December 31, 2021 of $45.9 million and the fair value of certain assets within an equity method investment held by the Company of $4.1 million, the Company's adjusted book value per common share(2) was $3.18 at December 31, 2021.
Commenting on the fourth quarter of 2021 financial results, Patrick J. Haveron and Lawrence F. Metz, Maiden’s Co-Chief Executive Officers stated, "We finished 2021 and head into 2022 on a successful footing, positioning Maiden for long-term success. Our strategic focus on our asset and capital management pillars continue to build out and by completing our first transactions with our Genesis Legacy Solutions ("GLS") unit, the third pillar of our strategy is now beginning to be realized. GLS has an attractive pipeline of opportunities which we expect to build on in 2022. While capital management made a more pronounced contribution to our 2021 results, we expect the other pillars of our strategy to play an increasing role in our performance in 2022 and beyond. These capital management initiatives have added $1.49 per common share since the fourth quarter of 2020."
Messrs. Haveron and Metz added, "Our strong fourth quarter earnings were partially offset by unrealized losses on our fixed income portfolio of $0.11 per common share as interest rates rose during the fourth quarter, slowing the continuing growth in our book value. During the fourth quarter, we had positive results from our expanded asset management activities and operating expenses continued to trend favorably. We believe our asset management and legacy underwriting strategies will exceed our cost of debt capital. As we continue to expand our asset management activities across a range of asset classes, including private equity, private credit, real estate, venture capital and other classes, we expect this portfolio to produce a range of contributions to our results, including current income, fees in selected instances as well as longer-term gains. We also believe that we are accumulating the necessary performance that will enable us to recognize the tax assets not currently reflected on our balance sheet in the future. The continuing net favorable trends in the run-off of our former reinsurance liabilities continues to track within our expectations but was impacted by higher current accident year losses on the run-off of these liabilities."
Consolidated Results for the Quarter Ended December 31, 2021
Net income available to Maiden common shareholders for the three months ended December 31, 2021 was $16.2 million compared to $47.7 million for the same period in 2020. The most significant items affecting our financial performance during the fourth quarter of 2021 on a comparative basis to the fourth quarter of 2020 included:
•gain from repurchase of preference shares of $3.8 million for the three months ended December 31, 2021 compared to $38.2 million in the same period in 2020;
•excluding the gain from repurchase of our preference shares, net income was $12.4 million for the three months ended December 31, 2021 compared to $9.5 million for the same period in 2020 largely due to the following factors:
◦underwriting income(4) of $5.2 million in fourth quarter of 2021 compared to $17.6 million in the same period in 2020. The decrease in underwriting income was largely due to:
▪favorable prior year loss development of $3.9 million in the fourth quarter of 2021 compared to $8.7 million during the same period in 2020 primarily related to the quota share reinsurance agreements with AmTrust Financial Services, Inc. (“AmTrust”), or the AmTrust Reinsurance segment; and
▪underwriting income of $1.3 million in the fourth quarter of 2021 on a current accident year basis compared to $8.9 million for the same period in 2020 on a current accident year basis, due to higher loss ratios on the run-off of unearned premium for terminated agreements in the AmTrust Reinsurance segment.
•total income from investment activities were $14.9 million for the three months ended December 31, 2021 compared to $15.3 million for the same period in 2020 which was comprised of:
◦net investment income of $7.4 million for the three months ended December 31, 2021 compared to $9.8 million for the same period in 2020;
◦net realized and unrealized gains on investment of $4.6 million for the three months ended December 31, 2021 compared to $0.3 million for the same period in 2020; and
◦interest in income of equity method investments of $2.8 million for the three months ended December 31, 2021 compared to interest in income of equity method investments of $5.3 million for the same period in 2020.
•net foreign exchange and other gains amounted to $1.6 million during the three months ended December 31, 2021, compared net foreign exchange and other losses of $7.9 million for the same period in 2020.
Net premiums written for the three months ended December 31, 2021 were $2.9 million compared to $10.9 million for the same period in 2020. Net premiums written in the Diversified Reinsurance segment decreased by $4.2 million or 43.1% for the three months ended December 31, 2021 compared to the same period in 2020 due to return of unearned premiums written in our German Auto quota share reinsurance contract which went into run-off on January 1, 2021. Direct gross premiums written by our wholly owned Swedish subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") increased by $0.9 million or 17.6% during the three months ended December 31, 2021, compared to the same period in 2020. Due to premium adjustments from the terminated AmTrust reinsurance contracts, there were $(2.6) million in net premiums written in the AmTrust Reinsurance segment during the three months ended December 31, 2021.
Net premiums earned decreased by $16.4 million or 55.9% for the three months ended December 31, 2021 compared to the same period in 2020 due to the combined impact of the terminated quota share contracts within the AmTrust Reinsurance segment and the Diversified Reinsurance segment due to run-off of the German Auto programs produced by our IIS unit.
Net investment income decreased by $2.4 million or 24.3% for the three months ended December 31, 2021 compared to the same period in 2020, primarily due to the decline in average aggregate fixed income assets of 29.8% in the same period. The decline in fixed income assets is largely due to the cessation of active reinsurance underwriting on prospective risks since January 1, 2019 which is responsible for significant negative operating cash flows as we continue to run-off our existing reinsurance liabilities. Net investment income also decreased due to the decline in annualized average book yields from fixed income assets to 1.9% for the three months ended December 31, 2021 compared to 2.1% for the same period in 2020.
Net realized and unrealized gains for the three months ended December 31, 2021 included the recognition of $0.7 million in unrealized losses related to an investment in an insurtech start-up company. Excluding the unrealized losses, net realized gains for the three months ended December 31, 2021 and 2020 reflect sales of corporate bonds for the settlement of claim payments to AmTrust.
Net loss and LAE decreased by $0.9 million during the three months ended December 31, 2021 compared to the same period in 2020. Net loss and LAE for the fourth quarter of 2021 was primarily impacted by net favorable prior year reserve development of $3.9 million compared to net favorable prior year reserve development of $8.7 million during the fourth quarter of 2020.
Commission and other acquisition expenses decreased by $3.3 million or 36.9% for the three months ended December 31, 2021, compared to the same period in 2020 due to significantly lower earned premiums in both of our reportable segments.
Total general and administrative expenses decreased by $6.7 million, or 50.8% for the three months ended December 31, 2021, compared to the same period in 2020 due to lower staff related costs. The Company estimates that it incurred certain operating expenses of $0.6 million during the three months ended December 31, 2021, which it believes will not recur in future periods. These costs include salary and related costs associated with headcount reductions.
Consolidated Results For the Year Ended December 31, 2021
Net income available to Maiden common shareholders for the year ended December 31, 2021 was $117.6 million compared to $80.0 million for the same period in 2020. The net improvement in our results for the year ended December 31, 2021 compared to the same period in 2020 was primarily due to:
•gain from repurchase of preference shares of $91.0 million for the year ended December 31, 2021 compared to $38.2 million in the same period in 2020;
•excluding the gain from repurchase of our preference shares, net income was $26.6 million for the year ended
December 31, 2021 compared to $41.8 million for the same period in 2020 largely due to the following factors:
◦underwriting income(4) of $11.6 million in the year ended December 31, 2021 compared to $17.3 million in the same period in 2020. The decrease in the underwriting income was largely due to:
▪favorable prior year loss development of $27.6 million for the year ended December 31, 2021 compared to $16.5 million during the same period in 2020 primarily related to the quota share reinsurance agreements with AmTrust; and offset by:
▪an underwriting loss of $16.0 million for the year ended December 31, 2021 on a current accident year basis compared to underwriting income of $0.8 million for the same period in 2020 on a current accident year basis, primarily caused by higher loss ratios on the run-off of unearned premium for terminated reinsurance contracts in our AmTrust Reinsurance segment.
▪total income from investment activities were $52.4 million for the year ended December 31, 2021 compared to $84.3 million for the same period in 2020 which was comprised of:
◦net investment income which was $32.0 million for the year ended December 31, 2021 compared to $54.8 million for the same period in 2020;
◦net realized and unrealized gains on investment which were $12.6 million for the year ended December 31, 2021 compared to $24.5 million for the same period in 2020; and
◦interest in income of equity method investments of $7.7 million for the year ended December 31, 2021 compared to an interest in income of equity method investments of $5.1 million for the same period in 2020.
▪foreign exchange gains of $7.5 million for the year ended December 31, 2021 compared to foreign exchange losses of $8.1 million for the same period in 2020.
Net premiums written for the year ended December 31, 2021 were $10.4 million compared to $28.4 million for the same period in 2020. Net premiums written in the Diversified Reinsurance segment decreased by $21.2 million or 56.8% for the year ended December 31, 2021 compared to the same period in 2020 due to the return of unearned premiums written in our German Auto quota share reinsurance contract which went into run-off on January 1, 2021. Direct premiums written by Maiden LF and Maiden GF increased by $2.3 million or 11.8% during the year ended December 31, 2021, compared to the same period in 2020. Due to premium adjustments from the terminated AmTrust reinsurance contracts, there were $(5.7) million in net premiums written in the AmTrust Reinsurance segment during the year ended December 31, 2021.
Net premiums earned decreased by $53.1 million or 50.0% for the year ended December 31, 2021 compared to the same period in 2020 due to the combined impact of the terminated quota share contracts within the AmTrust Reinsurance segment and the Diversified Reinsurance segment due to run-off of the German Auto programs produced by our IIS unit.
Net investment income decreased by $22.7 million or 41.5% for the year ended December 31, 2021 compared to the same period in 2020, primarily due to the decline in average aggregate fixed income assets of 28.8% in the same period. The decline in fixed income assets is largely due to the cessation of active reinsurance underwriting on prospective risks since January 1, 2019 which is responsible for significant negative operating cash flows as we continue to run-off our existing reinsurance liabilities. Net investment income also decreased due to the decline in annualized average book yields from fixed income assets to 1.9% for the year ended December 31, 2021 compared to 2.3% for the same period in 2020.
Net realized and unrealized gains for the year ended December 31, 2021 included the recognition of $0.2 million in unrealized gains related to an investment in an insurtech start-up company that was acquired by a special purpose acquisition company. In addition, realized gains for the year ended December 31, 2021 and 2020 reflect sales of corporate bonds for the settlement of claim payments to AmTrust.
Net loss and LAE decreased by $34.5 million during the year ended December 31, 2021 compared to the same period in 2020. Net loss and LAE for the year ended December 31, 2021 was impacted by net favorable prior year reserve development of $27.6 million compared to net favorable prior year reserve development of $16.5 million for the same period in 2020. The development was primarily generated within the AmTrust Reinsurance segment.
Commission and other acquisition expenses decreased by $14.0 million or 36.0% for the year ended December 31, 2021, compared to the same period in 2020 due to significantly lower earned premiums in both of our reportable segments.
Total general and administrative expenses decreased by $3.1 million, or 7.9% for the year ended December 31, 2021, compared to the same period in 2020 due to lower payroll costs and cash incentive staff compensation. The Company estimates that it incurred certain operating expenses of $3.6 million during the year ended December 31, 2021, which it believes will not recur in future periods. These costs include fees and write-offs related to the termination of our existing lease in Bermuda, salary and related costs associated with headcount reductions and certain regulatory costs in our international operations.
Non-GAAP Operating Results for the three and twelve months ended December 31, 2021
In addition to other adjustments, management has adjusted the GAAP net income and underwriting results by excluding incurred losses and LAE that are subject to the Loss Portfolio Transfer and Adverse Development Cover Agreement ("LPT/ADC Agreement") with Cavello Bay Reinsurance Ltd. ("Cavello"), a subsidiary of Enstar Group Limited. Such losses are fully recoverable from Cavello, and therefore adjusting for these losses shows the ultimate economic benefit of the LPT/ADC Agreement to Maiden.
Non-GAAP operating earnings were $2.3 million or $0.03 per diluted common share for the fourth quarter of 2021, compared to $45.0 million or $0.53 per diluted common share for the fourth quarter of 2020. Adjusted to include net realized and unrealized investment gains and an interest in income of equity method investments which are a recurring part of investment results with the Company’s underwriting activities in run-off, non-GAAP operating earnings was $9.8 million or $0.11 per diluted common share for the fourth quarter of 2021, compared to $50.6 million or $0.59 per diluted common share for the fourth quarter of 2020.
Non-GAAP operating earnings were $60.5 million or $0.70 per diluted common share for the year ended December 31, 2021, compared to $47.1 million or $0.55 per diluted common share for the year ended December 31, 2020. Adjusted to include net realized and unrealized investment gains and an interest in income of equity method investments which are a recurring part of investment results with the Company’s underwriting activities in run-off, non-GAAP operating earnings were $80.9 million or $0.93 per diluted common share for the year ended December 31, 2021, compared to $76.6 million or $0.90 per diluted common share for the year ended December 31, 2020.
Similar to the reported GAAP results, the improvement in non-GAAP operating results for the three and twelve months ended December 31, 2021 compared to the same respective periods in 2020 primarily reflects the gain from repurchase of preference shares of $3.8 million and $91.0 million recognized in the three and twelve months ended December 31, 2021, respectively.
The unamortized deferred gain on retroactive reinsurance under the LPT/ADC Agreement with Cavello was $45.9 million as of December 31, 2021, a decrease of $29.1 million compared to $74.9 million at December 31, 2020. The decrease in the unamortized deferred gain under the LPT/ADC Agreement for the year ended December 31, 2021 is attributable to $29.1 million in loss and LAE recognized as favorable loss development in the Company’s GAAP income statement that are covered by the LPT/ADC Agreement.
Adjusted for favorable loss development covered by the LPT/ADC Agreement of $4.8 million and $29.1 million during the three and twelve months ended December 31, 2021, respectively, the non-GAAP underwriting income(9) was $0.4 million and $17.5 million, respectively, compared to $12.5 million and $3.0 million for the same respective periods in 2020.
For the three and twelve months ended December 31, 2021, our non-GAAP operating earnings also included the underwriting results for business not covered by the LPT/ADC Agreement, specifically the Hospital Liability business and run-off of the AmTrust Reinsurance segment.
In addition, as previously noted, the Company estimates that it incurred operating expenses of $0.6 million and $3.6 million during the three and twelve months ended December 31, 2021, respectively, which it believes will not recur in future periods.
Please refer to the Non-GAAP Financial Measures tables in this release for additional information on these non-GAAP financial measures and reconciliation of these measures to the appropriate GAAP measures.
Annual Report on Form 10-K for Period Ended December 31, 2021 and Other Financial Matters
The Company’s Annual Report on Form 10-K for the period ended December 31, 2021 was filed with the U.S. Securities and Exchange Commission on March 14, 2022. Additional information on the matters reported in this news release along with other required disclosures can be found in that filing.
Total assets were $2.3 billion at December 31, 2021 compared to $2.9 billion at December 31, 2020. Shareholders' equity was $384.3 million at December 31, 2021 compared to $527.8 million at December 31, 2020. Adjusted shareholders' equity(2) was $434.2 million at December 31, 2021 compared to $602.8 million at December 31, 2020, which reflects the unamortized deferred gain under the LPT/ADC Agreement of $45.9 million at December 31, 2021 and $74.9 million at December 31, 2020; and 2) an adjustment of $4.1 million which reflects the equity accounting related to the fair value of certain hedged liabilities within an equity method investment in a limited partnership investment held by the Company wherein the ultimate realizable value of the asset supporting the hedged liabilities cannot currently be recognized at fair value ("LP Investment Adjustment") at December 31, 2021.
Effective October 1, 2021, GLS completed its first transaction, a loss portfolio transfer transaction which includes an adverse development cover. GLS continues to write additional retroactive reinsurance transactions consistent with its business plan. As
of December 31, 2021, GLS had losses and LAE reserves that it assumed through retroactive reinsurance contracts of $14.8 million. In addition to producing returns that exceed the target cost of capital, we expect the business produced through GLS should further enhance our ability to pursue the asset and capital management pillars of our business strategy.
The Company's wholly owned subsidiary, Maiden Holdings North America, Ltd., holds net operating loss carryforwards ("NOLs") which were $230.2 million as of December 31, 2021. These NOLs, in combination with additional net deferred tax assets primarily related to our insurance liabilities, result in a net deferred tax asset (before valuation allowance) of $90.1 million or $1.04 per common share as of December 31, 2021. These net deferred tax assets are not presently recognized on the Company’s balance sheet as a full valuation allowance is carried against them.
The Company no longer presents certain non-GAAP measures such as combined ratio and its related components in its news release, as it believes that as the run-off of its reinsurance portfolios progresses, such ratios are increasingly not meaningful and of less value to readers as they evaluate our financial results. For now, the Company continues to utilize such non-GAAP measures on an annual basis in its Annual Report on Form 10-K for the period ended December 31, 2021.
Preference Shares
On March 3, 2021, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance Ltd. (“Maiden Reinsurance") in accordance with its investment guidelines, of up to $100.0 million of the Company's preference shares from time to time at market prices in open market purchases or as may be privately negotiated.
On May 6, 2021, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines (as may be amended), of up to an additional $50.0 million of the Company's preference shares from time to time at market prices in open market purchases or as may be privately negotiated.
The authorizations that were approved on March 3, 2021 and May 6, 2021 are collectively referred to as the "2021 Preference Share Repurchase Program". The principal purpose of the cash tender offer on December 24, 2020 to purchase the Company’s preference shares and the 2021 Preference Share Repurchase Program is to adjust our capital structure to reflect current operations and the amount of capital required to operate Maiden Reinsurance.
The following table shows the summary of repurchases made of the Company's preference shares pursuant to the 2021 Preference Share Repurchase Program during the three and twelve months ended December 31, 2021:
| For the Three Months Ended December 31, 2021 | For the Year Ended December 31, 2021 | |||||||||||||||||||||||||
| Number of shares purchased | Average price of shares purchased | Number of shares purchased | Average price of shares purchased | |||||||||||||||||||||||
| Series A | — | $ | — | 3,519,093 | $ | 14.74 | ||||||||||||||||||||
| Series C | 109,520 | 12.20 | 3,026,764 | 14.36 | ||||||||||||||||||||||
| Series D | 218,819 | 12.19 | 2,858,155 | 14.27 | ||||||||||||||||||||||
| Total | 328,339 | 12.19 | 9,404,012 | 14.48 | ||||||||||||||||||||||
| Total price paid (in millions) | $ | 4.0 | $ | 136.2 | ||||||||||||||||||||||
| Gain on purchase (in millions) | $ | 3.8 | $ | 91.0 | ||||||||||||||||||||||
Subsequent to December 31, 2021, under the Rule 10b5-1 plan, the Company repurchased via the open market (i) 170,633 shares of the Company's 7.125% Non-Cumulative Preference Shares Series C at an average price of $11.67 per share, and (ii) 85,828 shares of the Company's 6.7% Non-Cumulative Preference Shares Series D at an average price of $10.97 per share for a total amount of $2.9 million. The acquisition by Maiden Reinsurance of these Preference Shares were made in compliance with the Company's investment guidelines previously approved by the Vermont Department of Financial Regulation. These purchases will result in a gain on purchase of approximately $3.3 million in the first quarter of 2022. The Company has a remaining authorization of $10.9 million for preference share repurchases.
The following table shows the Company's preference shares outstanding (including the total of the Company's preference shares held by Maiden Reinsurance pursuant to the 2020 Tender Offer and the 2021 Preference Share Repurchase Program) at March 14, 2022:
| Series A | Series C | Series D | Total | |||||||||||||||||||||||
| Outstanding shares issued by Maiden Holdings | 6,000,000 | 6,600,000 | 6,000,000 | 18,600,000 | ||||||||||||||||||||||
Total shares held by Maiden Reinsurance at March 14, 2022 | 4,064,311 | 4,400,863 | 4,022,894 | 12,488,068 | ||||||||||||||||||||||
Total shares held by non-affiliates at March 14, 2022 | 1,935,689 | 2,199,137 | 1,977,106 | 6,111,932 | ||||||||||||||||||||||
Percentage held by Maiden Reinsurance at March 14, 2022 | 67.7 | % | 66.7 | % | 67.0 | % | 67.1 | % | ||||||||||||||||||
Quarterly Dividends
The Company's Board of Directors did not authorize any quarterly dividends related to either its common shares or any series of its preference shares.
About Maiden Holdings, Ltd.
Maiden Holdings, Ltd. is a Bermuda-based holding company formed in 2007. Maiden creates shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. Maiden also provides a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies.
(1)(2)(4)(5)(9) Please refer to the Non-GAAP Financial Measures tables for additional information on these non-GAAP financial measures and reconciliation of these measures to GAAP measures.
Special Note about Forward Looking Statements
Certain statements in this press release, other than purely historical information, including estimates, projections, statements relating to the Company’s business plans, objectives and expected operating results and the assumptions upon which those statements are based are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include general statements both with respect to the Company and the insurance industry and generally are identified with the words "anticipate", "believe", "expect", "predict", "estimate", "intend", "plan", "project", "seek", "potential", "possible", "could", "might", "may", "should", "will", "would", "will be", "will continue", "will likely result" and similar expressions. In light of the risks and uncertainties inherent in all forward-looking statements, the inclusion of such statements in this press release should not be considered as a representation by the Company or any other person that the Company’s objectives or plans or other matters described in any forward-looking statement will be achieved. These statements are based on current plans, estimates, assumptions and expectations. Actual results may differ materially from those projected in such forward-looking statements and therefore, you should not place undue reliance on them. Important factors that could cause actual results to differ materially from those in such forward-looking statements are set forth in Item 1A "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Circumstances caused by the COVID-19 pandemic are complex, uncertain and rapidly evolving. We therefore may not be able to accurately predict the longer-term effects that the COVID-19 pandemic may have on our financial condition or results of operations. To the extent the COVID-19 pandemic adversely affects our financial condition or results of operations, it may also heighten additional risks described in "Part I, Item 1A, Risk Factors" of our Annual Report on Form 10-K for the year ended December 31, 2021.
The Company cautions that the list of important risk factors in its Annual Report on Form 10-K for the year ended December 31, 2021 is not intended to be and is not exhaustive. The Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law, and all subsequent written and oral forward-looking statements attributable to the Company or individuals acting on the Company’s behalf are expressly qualified in their entirety by this paragraph. If one or more risks or uncertainties materialize, or if the Company’s underlying assumptions prove to be incorrect, the Company’s actual results may vary materially from what was projected. Any forward-looking statements in this press release reflect the Company’s current view with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth, strategy and liquidity. Readers are cautioned not to place undue reliance on the forward-looking statements which speak only as of the dates of the documents in which such statements were made.
Any discrepancies between the amounts included in the results of operations discussion and the consolidated financial statement tables are due to rounding.
CONTACT:
Sard Verbinnen & Co.
Maiden-SVC@sardverb.com
MAIDEN HOLDINGS, LTD.
CONSOLIDATED BALANCE SHEETS
(In thousands of U.S. dollars, except share and per share data)
| December 31, 2021 | December 31, 2020 | |||||||||||||
| Audited | Audited | |||||||||||||
| ASSETS | ||||||||||||||
| Investments: | ||||||||||||||
Fixed maturities, available-for-sale, at fair value (amortized cost 2021 - $595,344; 2020 - $1,163,923) | $ | 597,145 | $ | 1,213,411 | ||||||||||
| Equity method investments | 83,742 | 43,136 | ||||||||||||
| Other investments | 141,725 | 63,760 | ||||||||||||
| Total investments | 822,612 | 1,320,307 | ||||||||||||
| Cash and cash equivalents | 26,668 | 74,040 | ||||||||||||
| Restricted cash and cash equivalents | 39,419 | 61,786 | ||||||||||||
| Accrued investment income | 5,695 | 11,240 | ||||||||||||
| Reinsurance balances receivable, net | 19,507 | 5,777 | ||||||||||||
| Reinsurance recoverable on unpaid losses | 562,845 | 592,571 | ||||||||||||
| Loan to related party | 167,975 | 167,975 | ||||||||||||
Deferred commission and other acquisition expenses, net | 36,703 | 51,903 | ||||||||||||
| Funds withheld receivable | 636,412 | 654,805 | ||||||||||||
| Other assets | 4,774 | 8,051 | ||||||||||||
| Total assets | $ | 2,322,610 | $ | 2,948,455 | ||||||||||
| LIABILITIES | ||||||||||||||
| Reserve for loss and loss adjustment expenses | $ | 1,489,373 | $ | 1,893,299 | ||||||||||
| Unearned premiums | 100,131 | 144,271 | ||||||||||||
| Deferred gain on retroactive reinsurance | 48,960 | 74,941 | ||||||||||||
| Accrued expenses and other liabilities | 44,542 | 53,002 | ||||||||||||
| Senior notes - principal amount | 262,500 | 262,500 | ||||||||||||
| Less: unamortized debt issuance costs | 7,153 | 7,374 | ||||||||||||
| Senior notes, net | 255,347 | 255,126 | ||||||||||||
| Total liabilities | 1,938,353 | 2,420,639 | ||||||||||||
| Commitments and Contingencies | ||||||||||||||
| EQUITY | ||||||||||||||
| Preference shares | 159,210 | 394,310 | ||||||||||||
| Common shares | 923 | 898 | ||||||||||||
| Additional paid-in capital | 768,650 | 756,122 | ||||||||||||
| Accumulated other comprehensive (loss) income | (12,215) | 23,857 | ||||||||||||
| Accumulated deficit | (498,295) | (615,837) | ||||||||||||
| Treasury shares, at cost | (34,016) | (31,534) | ||||||||||||
| Total Equity | 384,257 | 527,816 | ||||||||||||
| Total Liabilities and Equity | $ | 2,322,610 | $ | 2,948,455 | ||||||||||
Book value per common share(1) | $ | 2.60 | $ | 1.57 | ||||||||||
| Common shares outstanding | 86,467,242 | 84,801,161 | ||||||||||||
MAIDEN HOLDINGS, LTD.
CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
(In thousands of U.S. dollars, except share and per share data)
| For the Three Months Ended December 31, | For the Year Ended December 31, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
Revenues: | ||||||||||||||||||||||||||
| Gross premiums written | $ | 3,073 | $ | 11,156 | $ | 10,938 | $ | 31,389 | ||||||||||||||||||
| Net premiums written | $ | 2,885 | $ | 10,939 | $ | 10,403 | $ | 28,432 | ||||||||||||||||||
| Change in unearned premiums | 10,002 | 18,314 | 42,590 | 77,649 | ||||||||||||||||||||||
Net premiums earned | 12,887 | 29,253 | 52,993 | 106,081 | ||||||||||||||||||||||
Other insurance revenue | 121 | 357 | 1,067 | 1,276 | ||||||||||||||||||||||
Net investment income | 7,417 | 9,802 | 32,013 | 54,761 | ||||||||||||||||||||||
| Net realized and unrealized gains on investment | 4,635 | 273 | 12,648 | 24,473 | ||||||||||||||||||||||
Total other-than-temporary impairment losses | — | — | — | (2,468) | ||||||||||||||||||||||
Total revenues | 25,060 | 39,685 | 98,721 | 184,123 | ||||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||
Net loss and loss adjustment expenses | (239) | 640 | 7,307 | 41,799 | ||||||||||||||||||||||
Commission and other acquisition expenses | 5,686 | 9,018 | 24,840 | 38,796 | ||||||||||||||||||||||
General and administrative expenses | 6,467 | 13,147 | 36,020 | 39,118 | ||||||||||||||||||||||
Total expenses | 11,914 | 22,805 | 68,167 | 119,713 | ||||||||||||||||||||||
Other expenses | ||||||||||||||||||||||||||
Interest and amortization expenses | 4,832 | 4,831 | 19,327 | 19,324 | ||||||||||||||||||||||
| Foreign exchange and other (gains) losses | (1,615) | 7,892 | (7,685) | 8,526 | ||||||||||||||||||||||
| Total other expenses | 3,217 | 12,723 | 11,642 | 27,850 | ||||||||||||||||||||||
| Income before income taxes | 9,929 | 4,157 | 18,912 | 36,560 | ||||||||||||||||||||||
| Less: income tax expense (benefit) | 378 | (118) | 15 | (104) | ||||||||||||||||||||||
| Add: interest in income of equity method investments | 2,836 | 5,252 | 7,748 | 5,098 | ||||||||||||||||||||||
| Net income | 12,387 | 9,527 | 26,645 | 41,762 | ||||||||||||||||||||||
| Gain from repurchase of preference shares | 3,830 | 38,195 | 90,998 | 38,195 | ||||||||||||||||||||||
| Net income available to Maiden common shareholders | $ | 16,217 | $ | 47,722 | $ | 117,643 | $ | 79,957 | ||||||||||||||||||
| Basic and diluted earnings per share available to Maiden common shareholders | $ | 0.19 | $ | 0.56 | $ | 1.35 | $ | 0.93 | ||||||||||||||||||
| Annualized return on average common equity | 29.2 | % | 183.8 | % | 65.6 | % | 90.7 | % | ||||||||||||||||||
| Weighted average number of common shares - basic | 86,457,797 | 84,786,168 | 86,068,278 | 84,333,514 | ||||||||||||||||||||||
| Adjusted weighted average number of common shares and assumed conversions - diluted | 86,462,134 | 84,786,168 | 86,072,667 | 84,333,655 | ||||||||||||||||||||||
MAIDEN HOLDINGS, LTD.
SUPPLEMENTAL FINANCIAL DATA - SEGMENT INFORMATION (Unaudited)
(in thousands of U.S. dollars)
| For the Three Months Ended December 31, 2021 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Gross premiums written | $ | 5,686 | $ | (2,613) | $ | 3,073 | ||||||||||||||
Net premiums written | $ | 5,498 | $ | (2,613) | $ | 2,885 | ||||||||||||||
Net premiums earned | $ | 6,958 | $ | 5,929 | $ | 12,887 | ||||||||||||||
Other insurance revenue | 121 | — | 121 | |||||||||||||||||
Net loss and loss adjustment expenses ("loss and LAE") | (1,070) | 1,309 | 239 | |||||||||||||||||
Commission and other acquisition expenses | (3,425) | (2,261) | (5,686) | |||||||||||||||||
General and administrative expenses(3) | (1,637) | (729) | (2,366) | |||||||||||||||||
Underwriting income (4) | $ | 947 | $ | 4,248 | 5,195 | |||||||||||||||
| Reconciliation to net income | ||||||||||||||||||||
| Net investment income and net realized and unrealized gains on investment | 12,052 | |||||||||||||||||||
Interest and amortization expenses | (4,832) | |||||||||||||||||||
| Foreign exchange and other gains, net | 1,615 | |||||||||||||||||||
Other general and administrative expenses(3) | (4,101) | |||||||||||||||||||
| Income tax expense | (378) | |||||||||||||||||||
| Interest in income of equity method investments | 2,836 | |||||||||||||||||||
| Net income | $ | 12,387 | ||||||||||||||||||
| For the Three Months Ended December 31, 2020 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Gross premiums written | $ | 9,884 | $ | 1,272 | $ | 11,156 | ||||||||||||||
Net premiums written | $ | 9,667 | $ | 1,272 | $ | 10,939 | ||||||||||||||
Net premiums earned | $ | 12,466 | $ | 16,787 | $ | 29,253 | ||||||||||||||
Other insurance revenue | 357 | — | 357 | |||||||||||||||||
Net loss and LAE | (5,206) | 4,566 | (640) | |||||||||||||||||
Commission and other acquisition expenses | (4,918) | (4,100) | (9,018) | |||||||||||||||||
General and administrative expenses(3) | (1,759) | (611) | (2,370) | |||||||||||||||||
Underwriting income(4) | $ | 940 | $ | 16,642 | 17,582 | |||||||||||||||
| Reconciliation to net income | ||||||||||||||||||||
| Net investment income and net realized and unrealized gains on investment | 10,075 | |||||||||||||||||||
Interest and amortization expenses | (4,831) | |||||||||||||||||||
| Foreign exchange and other losses, net | (7,892) | |||||||||||||||||||
Other general and administrative expenses(3) | (10,777) | |||||||||||||||||||
| Income tax benefit | 118 | |||||||||||||||||||
| Interest in income of equity method investments | 5,252 | |||||||||||||||||||
| Net income | $ | 9,527 | ||||||||||||||||||
MAIDEN HOLDINGS, LTD.
SUPPLEMENTAL FINANCIAL DATA - SEGMENT INFORMATION (Unaudited)
(in thousands of U.S. dollars)
| For the Year Ended December 31, 2021 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Gross premiums written | $ | 16,633 | $ | (5,695) | $ | 10,938 | ||||||||||||||
Net premiums written | $ | 16,098 | $ | (5,695) | $ | 10,403 | ||||||||||||||
Net premiums earned | $ | 27,681 | $ | 25,312 | $ | 52,993 | ||||||||||||||
Other insurance revenue | 1,067 | — | 1,067 | |||||||||||||||||
Net loss and LAE | (4,286) | (3,021) | (7,307) | |||||||||||||||||
Commission and other acquisition expenses | (15,093) | (9,747) | (24,840) | |||||||||||||||||
General and administrative expenses(3) | (7,827) | (2,514) | (10,341) | |||||||||||||||||
Underwriting income(4) | $ | 1,542 | $ | 10,030 | 11,572 | |||||||||||||||
| Reconciliation to net income | ||||||||||||||||||||
| Net investment income and net realized and unrealized gains on investment | 44,661 | |||||||||||||||||||
Interest and amortization expenses | (19,327) | |||||||||||||||||||
| Foreign exchange and other gains, net | 7,685 | |||||||||||||||||||
Other general and administrative expenses(3) | (25,679) | |||||||||||||||||||
| Income tax expense | (15) | |||||||||||||||||||
| Interest in income of equity method investments | 7,748 | |||||||||||||||||||
| Net income | $ | 26,645 | ||||||||||||||||||
| For the Year Ended December 31, 2020 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Gross premiums written | $ | 40,457 | $ | (9,068) | $ | 31,389 | ||||||||||||||
Net premiums written | $ | 37,258 | $ | (8,826) | $ | 28,432 | ||||||||||||||
Net premiums earned | $ | 47,847 | $ | 58,234 | $ | 106,081 | ||||||||||||||
Other insurance revenue | 1,276 | — | 1,276 | |||||||||||||||||
Net loss and LAE | (24,909) | (16,890) | (41,799) | |||||||||||||||||
Commission and other acquisition expenses | (18,475) | (20,321) | (38,796) | |||||||||||||||||
General and administrative expenses(3) | (6,936) | (2,552) | (9,488) | |||||||||||||||||
Underwriting (loss) income(4) | $ | (1,197) | $ | 18,471 | 17,274 | |||||||||||||||
| Reconciliation to net income | ||||||||||||||||||||
| Net investment income and net realized and unrealized gains on investment | 79,234 | |||||||||||||||||||
Total other-than-temporary impairment losses | (2,468) | |||||||||||||||||||
Interest and amortization expenses | (19,324) | |||||||||||||||||||
| Foreign exchange and other losses, net | (8,526) | |||||||||||||||||||
Other general and administrative expenses(3) | (29,630) | |||||||||||||||||||
| Income tax benefit | 104 | |||||||||||||||||||
| Interest in income of equity method investments | 5,098 | |||||||||||||||||||
| Net income | $ | 41,762 | ||||||||||||||||||
MAIDEN HOLDINGS, LTD.
NON-GAAP FINANCIAL MEASURES (Unaudited)
(In thousands of U.S. dollars, except share and per share data)
| For the Three Months Ended December 31, | For the Year Ended December 31, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
Non-GAAP operating earnings(5) | $ | 2,346 | $ | 45,035 | $ | 60,481 | $ | 47,076 | ||||||||||||||||||
Non-GAAP basic and diluted operating earnings per common share available to Maiden common shareholders(5) | $ | 0.03 | $ | 0.53 | $ | 0.70 | $ | 0.55 | ||||||||||||||||||
Annualized non-GAAP operating return on average adjusted common equity(6) | 3.4 | % | 99.1 | % | 25.0 | % | 25.9 | % | ||||||||||||||||||
| Reconciliation of net income available to Maiden common shareholders to non-GAAP operating earnings: | ||||||||||||||||||||||||||
| Net income available to Maiden common shareholders | $ | 16,217 | $ | 47,722 | $ | 117,643 | $ | 79,957 | ||||||||||||||||||
| Add (subtract): | ||||||||||||||||||||||||||
| Net realized and unrealized gains on investment | (4,635) | (273) | (12,648) | (24,473) | ||||||||||||||||||||||
| Total other-than-temporary impairment losses | — | — | — | 2,468 | ||||||||||||||||||||||
| Foreign exchange and other (gains) losses | (1,615) | 7,892 | (7,685) | 8,526 | ||||||||||||||||||||||
| Interest in income of equity method investments | (2,836) | (5,252) | (7,748) | (5,098) | ||||||||||||||||||||||
| Decrease in deferred gain on retroactive reinsurance | (4,785) | (5,054) | (29,081) | (14,304) | ||||||||||||||||||||||
Non-GAAP operating earnings (5) | $ | 2,346 | $ | 45,035 | $ | 60,481 | $ | 47,076 | ||||||||||||||||||
| Weighted average number of common shares - basic | 86,457,797 | 84,786,168 | 86,068,278 | 84,333,514 | ||||||||||||||||||||||
| Adjusted weighted average number of common shares and assumed conversions - diluted | 86,462,134 | 84,786,168 | 86,072,667 | 84,333,655 | ||||||||||||||||||||||
| Reconciliation of diluted earnings per share available to Maiden common shareholders to non-GAAP diluted operating earnings per share available to Maiden common shareholders: | ||||||||||||||||||||||||||
| Diluted earnings per share available to Maiden common shareholders | $ | 0.19 | $ | 0.56 | $ | 1.35 | $ | 0.93 | ||||||||||||||||||
| Add (subtract): | ||||||||||||||||||||||||||
| Net realized and unrealized gains on investment | (0.05) | — | (0.14) | (0.29) | ||||||||||||||||||||||
| Total other-than-temporary impairment losses | — | — | — | 0.03 | ||||||||||||||||||||||
| Foreign exchange and other (gains) losses | (0.02) | 0.09 | (0.09) | 0.11 | ||||||||||||||||||||||
| Interest in income of equity method investments | (0.03) | (0.06) | (0.09) | (0.06) | ||||||||||||||||||||||
| Decrease in deferred gain on retroactive reinsurance | (0.06) | (0.06) | (0.33) | (0.17) | ||||||||||||||||||||||
| Non-GAAP diluted operating earnings per share available to Maiden common shareholders | $ | 0.03 | $ | 0.53 | $ | 0.70 | $ | 0.55 | ||||||||||||||||||
| Non-GAAP Underwriting Results and Non-GAAP Net Loss and LAE | ||||||||||||||||||||||||||
| Gross premiums written | $ | 3,073 | $ | 11,156 | $ | 10,938 | $ | 31,389 | ||||||||||||||||||
| Net premiums written | $ | 2,885 | $ | 10,939 | $ | 10,403 | $ | 28,432 | ||||||||||||||||||
| Net premiums earned | $ | 12,887 | $ | 29,253 | $ | 52,993 | $ | 106,081 | ||||||||||||||||||
| Other insurance revenue | 121 | 357 | 1,067 | 1,276 | ||||||||||||||||||||||
Non-GAAP net loss and LAE(9) | (4,546) | (5,694) | (36,388) | (56,103) | ||||||||||||||||||||||
| Commission and other acquisition expenses | (5,686) | (9,018) | (24,840) | (38,796) | ||||||||||||||||||||||
| General and administrative expenses | (2,366) | (2,370) | (10,341) | (9,488) | ||||||||||||||||||||||
Non-GAAP underwriting income (loss)(9) | $ | 410 | $ | 12,528 | $ | (17,509) | $ | 2,970 | ||||||||||||||||||
| Net loss and LAE | $ | (239) | $ | 640 | $ | 7,307 | $ | 41,799 | ||||||||||||||||||
Less: favorable prior year loss development subject to LPT/ADC Agreement | (4,785) | (5,054) | (29,081) | (14,304) | ||||||||||||||||||||||
Non-GAAP net loss and LAE(9) | $ | 4,546 | $ | 5,694 | $ | 36,388 | $ | 56,103 | ||||||||||||||||||
MAIDEN HOLDINGS, LTD.
NON-GAAP FINANCIAL MEASURES (Unaudited)
(In thousands of U.S. dollars, except share and per share data)
| December 31, 2021 | December 31, 2020 | ||||||||||
| Investable assets: | |||||||||||
| Total investments | $ | 822,612 | $ | 1,320,307 | |||||||
| Cash and cash equivalents | 26,668 | 74,040 | |||||||||
| Restricted cash and cash equivalents | 39,419 | 61,786 | |||||||||
| Loan to related party | 167,975 | 167,975 | |||||||||
| Funds withheld receivable | 636,412 | 654,805 | |||||||||
Total investable assets(7) | $ | 1,693,086 | $ | 2,278,913 | |||||||
| Capital: | |||||||||||
Preference shares | $ | 159,210 | $ | 394,310 | |||||||
Common shareholders' equity | 225,047 | 133,506 | |||||||||
Total shareholders' equity | 384,257 | 527,816 | |||||||||
2016 Senior Notes | 110,000 | 110,000 | |||||||||
2013 Senior Notes | 152,500 | 152,500 | |||||||||
Total capital resources(8) | $ | 646,757 | $ | 790,316 | |||||||
Reconciliation of total shareholders' equity to adjusted shareholders' equity: | |||||||||||
Total Shareholders’ Equity | $ | 384,257 | $ | 527,816 | |||||||
| LP Investment Adjustment | 4,083 | — | |||||||||
| Unamortized deferred gain on LPT/ADC Agreement | 45,860 | 74,941 | |||||||||
Adjusted shareholders' equity(2) | $ | 434,200 | $ | 602,757 | |||||||
Reconciliation of book value per common share to adjusted book value per common share: | |||||||||||
Book value per common share | $ | 2.60 | $ | 1.57 | |||||||
| LP Investment Adjustment | 0.05 | — | |||||||||
Unamortized deferred gain on retroactive reinsurance | 0.53 | 0.89 | |||||||||
Adjusted book value per common share(2) | $ | 3.18 | $ | 2.46 | |||||||
| (1) Book value per common share is calculated using common shareholders’ equity (shareholders' equity excluding the aggregate liquidation value of our preference shares) divided by the number of common shares outstanding. Management uses growth in this metric as a prime measure of the value we are generating for our common shareholders, because management believes that growth in this metric ultimately results in growth in the Company’s common share price. This metric is impacted by the Company’s net income and external factors, such as interest rates, which can drive changes in unrealized gains or losses on our investment portfolio, as well as share repurchases. | ||
| (2) Adjusted Total Shareholders' Equity and Adjusted Book Value per Common Share: Management has adjusted GAAP shareholders' equity by adding the following items: 1) the unamortized deferred gain on retroactive reinsurance arising from the LPT/ADC Agreement; and 2) an adjustment which reflects the equity method accounting related to the fair value of certain hedged liabilities within an equity method investment in a limited partnership held by the Company wherein the ultimate realizable value of the asset supporting the hedged liabilities cannot currently be recognized at fair value. As a result, by virtue of this adjustment, management has also computed the Adjusted Book Value per Common Share. The deferred gain on retroactive reinsurance represents amounts estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement. The LP Investment Adjustment reflects the fair value of the assets not presently able to be recognized currently. We believe reflecting the economic benefit of both items is helpful to understand future trends in our operations, which will improve the Company's shareholders' equity over the settlement or contract periods, respectively. | ||
| (3) Underwriting related general and administrative expenses is a non-GAAP measure and includes expenses which are segregated for analytical purposes as a component of underwriting income (loss). | ||
| (4) Underwriting income or loss is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities. For purposes of these non-GAAP operating measures, the fee-generating business, which is included in our Diversified Reinsurance segment, is considered part of the underwriting operations of the Company. Management believes that this measure is important in evaluating the underwriting performance of the Company and its segments. This measure is also a useful tool to measure the profitability of the Company separately from the investment results and is also a widely used performance indicator in the insurance industry. | ||
| (5) Non-GAAP operating earnings and non-GAAP basic and diluted operating earnings per common share are non-GAAP financial measure defined by the Company as net income excluding realized investment gains and losses, total other-than-temporary impairment losses, foreign exchange and other gains and losses, interest in income of equity method investment, and (favorable) adverse prior year loss development subject to LPT/ADC Agreement and should not be considered as an alternative to net income. The Company's management believes that the use of non-GAAP operating earnings and non-GAAP diluted operating earnings per common share enables investors and other users of the Company’s financial information to analyze its performance in a manner similar to how management analyzes performance. Management also believes that these measures generally follow industry practice therefore allowing the users of financial information to compare the Company’s performance with its industry peer group, and that the equity analysts and certain rating agencies which follow the Company, and the insurance industry as a whole, generally exclude these items from their analyses for the same reasons. Non-GAAP operating earnings should not be viewed as a substitute for U.S. GAAP net income. | ||
| (6) Non-GAAP operating return on average adjusted common equity is a non-GAAP financial measure. Management uses non-GAAP operating return on average adjusted common shareholders' equity as a measure of profitability that focuses on the return to common shareholders. It is calculated using non-GAAP operating earnings divided by average adjusted common shareholders' equity adjusted for the deferred gain on LPT/ADC Agreement and LP Investment Adjustment. | ||
| (7) Investable assets are the total of the Company's investments, cash and cash equivalents, loan to a related party and funds withheld receivable. | ||
| (8) Total capital resources are the sum of the Company's principal amount of debt and shareholders' equity. | ||
| (9) Non-GAAP net loss and LAE and Non-GAAP underwriting income (loss): Management has further adjusted the net loss and LAE and underwriting income (loss) (as defined above) by recognizing into income the (favorable) adverse prior year loss development subject to LPT/ADC Agreement relating to losses subject to that agreement. The deferred gain represents amounts estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement on Maiden's underwriting income (loss). Management believes reflecting the economic benefit of this retroactive reinsurance agreement is helpful for understanding future trends in our operations. | ||
Exhibit 99.2
PRESS RELEASE
Maiden Holdings, Ltd. Releases
Fourth Quarter and Year-End 2021 Earnings
PEMBROKE, Bermuda, March 14, 2022 (GLOBE NEWSWIRE) -- Maiden Holdings, Ltd. (NASDAQ:MHLD) ("Maiden") has released its fourth quarter and year-end 2021 financial results via its investor relations website. Concurrent with releasing its results, Maiden also published an investor update presentation. Both documents are posted at https://www.maiden.bm/investor_relations.
About Maiden Holdings, Ltd.
Maiden Holdings, Ltd. is a Bermuda-based holding company formed in 2007. Maiden creates shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. Maiden also provides a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies.
Maiden Holdings, Ltd. Investor Update March 2022
Investor Disclosures 1 Forward Looking Statements This presentation contains "forward-looking statements" which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on the Maiden Holdings, Ltd.’s (the “Company”) concerning future developments and their potential effects on the Company. There can be no assurance that actual developments will be those anticipated by the Company. Actual results may differ materially from those projected as a result of significant risks and uncertainties, including non-receipt of the expected payments, changes in interest rates, effect of the performance of financial markets on investment income and fair values of investments, developments of claims and the effect on loss reserves, accuracy in projecting loss reserves, the impact of competition and pricing environments, changes in the demand for the Company's products, the effect of general economic conditions and unusual frequency of storm activity, adverse state and federal legislation, regulations and regulatory investigations into industry practices, developments relating to existing agreements, heightened competition, changes in pricing environments, and changes in asset valuations. Additional information about these risks and uncertainties, as well as others that may cause actual results to differ materially from those projected is contained in Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC. The Company undertakes no obligation to publicly update any forward-looking statements, except as may be required by law. Any discrepancies between the amounts included in this presentation and amounts included in the Company’s Form 10-K for the year ended December 31, 2021, filed with the SEC are due to rounding. Non-GAAP Financial Measures In addition to the Summary Consolidated Balance Sheets and Consolidated Statements of Income, management uses certain key financial measures, some of which are non-GAAP measures, to evaluate the Company's financial performance and the overall growth in value generated for the Company’s common shareholders. Management believes that these measures, which may be defined differently by other companies, explain the Company’s results to investors in a manner that allows for a more complete understanding of the underlying trends in the Company’s business. The non-GAAP measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP. See the Appendix of this presentation for a reconciliation of the Company’s non-GAAP measures to the nearest GAAP measure.
Maiden Holdings 2021 Highlights 2 • GAAP book value increased 66% to $2.60 per common share o Non-GAAP book value increased 29% to $3.18 per common share • GAAP net income was $117.6 million, a 47% increase over 2020 o Q4 net income available to common shareholders $16.2 million or $0.19 per share • Executed in each pillar of our business strategy during 2021 o Asset management – increased alternative investments by 111% to $225.5 million o Legacy underwriting – completed our first transactions through Genesis Legacy Solutions (“GLS”) in Q4, now with nearly $40 million in reserves in Q1 2022 o Capital management – repurchased $136.2 million preference shares, increasing book value by $1.05 per common share through 12/31/2021 o As of March 11, 2022, now own more than 2/3 of each series of preference shares • Deferred tax asset = $1.04 per share at December 31 – still carries full valuation allowance o Not recognized as an asset on balance sheet currently o Growing but not yet sufficient positive evidence to reduce valuation allowance * Please see the definition of non-GAAP financial measures in the Appendix of this presentation for additional important information regarding certain terms used herein
Maiden Holdings – Q4 2021 Results 3* Please see the definition of non-GAAP financial measures in the Appendix of this presentation for additional important information regarding certain terms used herein ($ millions, except per share amounts) Q4 2021 Q4 2020 Comments Net Income and Per Share Data GAAP Net Income (excluding gains from preference share repurchases) $12.4 $9.5 • Lower operating expenses and higher foreign exchange gains partially offset primarily by lower underwriting income and to a lesser extent investment results GAAP Net Income Attributable to Common Shares Per common share $16.2 $0.19 $47.7 $0.56 • Net income attributable to Maiden common shareholders in Q4 2021 includes $3.8 million of gains from partial redemption of preference shares, down from $38.2 million in Q4 2020 • Summary GAAP Balance Sheet, Income Statement and Non-GAAP Financial Measures in Appendix Key Income Statement Details Underwriting Income $5.2 $17.6 • Lower favorable prior year development and higher current accident year results from run-off of the AmTrust Reinsurance business - Diversified Reinsurance segment results stable Investment Results $14.9 $15.3 • Lower investment income of $7.4 million vs. $9.8 million in Q4 2020 • Realized gains of $4.6 million in Q4 2021 attributable to sale of fixed income securities compared to $0.3 million in Q4 2020 • Income on equity method investments was $2.8 million in Q4 2021 vs. $5.3 million in Q4 2020 Operating Expenses $6.5 $13.1 • Operating expenses continued to trend lower as G&A expenses decreased by $6.7 million, or 51% in Q4 2021 vs. Q4 2020 primarily due to lower staff costs • Non-recurring expenses totaled $0.6 million in Q4 2020 vs. $4.9 million in Q4 2020 Foreign Exchange and Other Gains (Losses) $1.6 ($7.9) • Primarily due to reserve revaluation due to strengthening of U.S. dollar relative to Euro
Maiden Holdings Business Strategy 4 • We create shareholder value by actively managing and allocating our assets and capital o We leverage our deep knowledge of the insurance and related financial services industries into ownership and management of businesses and assets with the opportunity for increased returns o Change in strategy since 2019 have allowed us to more flexibly allocate capital to activities we believe will produce the greatest returns for shareholders • Our strategy has three principal areas of focus o Asset management – investing in assets and asset classes in a prudent but expansive manner in order to maximize investment returns o We limit the insurance risk we assume relative to the assets we hold and maintain required regulatory capital at very strong levels to manage our aggregate risk profile o Legacy underwriting - judiciously building a portfolio of run-off acquisitions and retroactive reinsurance transactions which we believe will produce attractive underwriting returns o Capital management - effectively managing capital and when appropriate, repurchasing securities or returning capital to enhance common shareholder returns • We believe these areas of strategic focus will enhance our profitability o We believe our strategy increases the likelihood of fully utilizing the significant tax NOL carryforwards which would create additional common shareholder value o Expected returns from each strategic pillar are evaluated relative to our cost of debt capital
Asset Management Update • Increased alternative investments to $225.5 million during 2021 • Alternative investments expected to produce a range of contributions to results • Current income, longer-term gains, fees in selected instances • Targeted returns in alternative investment portfolio exceed cost of debt capital • Most alternative investments not marked to fair value yet - too early in life cycle of investments • Fixed income returns in Q4 impacted by rising interest rates 5 Total fixed income and cash, 39% Loan to related party, 10% Funds withheld receivable, 38% Alternative Investments, 13% Q4 2021 - Investable Asset Allocation Private Equity, 21% Private Credit, 17% Hedge Funds, 15% Alternatives, 21% Venture Capital, 3% Real Estate, 23% Q4 2021 - Alternative Investments * Please see the definition of non-GAAP financial measures in the Appendix of this presentation for additional important information regarding certain terms used herein Performance of Investable Assets ** Fixed Income *** Alternative Investments 2021 2020 2021 2020 Three Months Ended December 31, 2021 Gross Returns 0.1% 0.8% 3.8% 6.0% Net Returns 0.1% 0.7% 3.8% 4.5% Twelve Months Ended December 31, 2021 Gross Returns 0.8% 3.1% 4.8% 8.8% Net Returns 0.7% 3.1% 3.9% 6.8% ** Excludes foreign currency gains/losses *** Fixed income includes AFS, cash, funds withheld receivable, and loan to related party
Legacy Underwriting Update 6 • GLS formed in November 2020 • Effective October 1, 2021, GLS completed its first transaction, a loss portfolio transfer transaction which includes an adverse development cover • As of December 31, 2021, GLS had losses and LAE reserves that it assumed through retroactive reinsurance contracts of $14.8 million • GLS continues to write additional retroactive reinsurance transactions in 2022 consistent with its business plan • GLS reserves currently approaching $40 million in Q1 2022 • Robust pipeline for additional transactions consistent with business plan
Capital Management Update 7 • Active Capital Management Continued in Q4 2021 and Q1 2022 o 12,231,607 shares repurchased since launch of tender offer in 2020 and repurchase program in 2021 and Q1 2022, adding $1.53 in book value per common share o During Q4 2021, Maiden Reinsurance Ltd. (“MRL”) repurchased 328,339 shares at an average cost of $12.19 per share for a total cost of $4.0 million o In 2022 through March 11, pursuant to a 10b5-1 plan, 256,461 shares repurchased at cost of $2.9 million and gain of $3.3 million or $0.04 per common share o $10.9 million of unutilized authorization remaining as of March 11, 2022 • As of March 11, 2022, MRL’s ownership percentage of each series of preferred shares is as follows Series % Owned Series A 67.7% Series C 66.7% Series D 67.0% Total 67.1% • Maiden expects to continue to evaluate its capital management options as its broader strategy progresses * Please see the definition of non-GAAP financial measures in the Appendix of this presentation for additional important information regarding certain terms used herein
Maiden Holdings, Ltd. Investor Update - Appendix Fourth Quarter and Year Ended December 31, 2021 Financial Data
Summary Consolidated Balance Sheet 9 December 31, 2021 December 31, 2020 Assets Total investments $ 822,612 $ 1,320,307 Cash and cash equivalents (including restricted) 66,087 135,826 Reinsurance balances receivable, net 19,507 5,777 Reinsurance recoverable on unpaid losses 562,845 592,571 Loan to related party 167,975 167,975 Funds withheld receivable 636,412 654,805 Other assets 47,172 71,194 Total Assets $ 2,322,610 $ 2,948,455 Liabilities and Equity Liabilities Reserve for loss and loss adjustment expenses $ 1,489,373 $ 1,893,299 Unearned premiums 100,131 144,271 Deferred gain on retroactive reinsurance 48,960 74,941 Accrued expenses and other l iabilities 44,542 53,002 Senior notes, net 255,347 255,126 Total Liabilities 1,938,353 2,420,639 Equity 384,257 527,816 Total Liabilities and Equity $ 2,322,610 $ 2,948,455 Book value per common share(1) $ 2.60 $ 1.57 Common shares outstanding 86,467,242 84,801,161 Maiden Holdings, Ltd. Consolidated Balance Sheets (in thousands (000's), except per share data)
Consolidated Statements of Income 10 Revenues: Gross premiums wri tten $ 3,073 $ 11,156 $ 10,938 $ 31,389 Net premiums wri tten $ 2,885 $ 10,939 $ 10,403 $ 28,432 Change in unearned premiums 10,002 18,314 42,590 77,649 Net premiums earned 12,887 29,253 52,993 106,081 Other insurance revenue 121 357 1,067 1,276 Net investment income 7,417 9,802 32,013 54,761 Net rea l ized ga ins on investment 4,635 273 12,648 24,473 Total other-than-temporary impairment losses - - (2,468) Total revenues 25,060 39,685 98,721 184,123 Expenses: Net loss and loss adjustment expenses (239) 640 7,307 41,799 Commiss ion and other acquis i tion expenses 5,686 9,018 24,840 38,796 General and adminis trative expenses 6,467 13,147 36,020 39,118 Total expenses 11,914 22,805 68,167 119,713 Other expenses: Interest and amortization expenses (4,832) (4,831) (19,327) (19,324) Foreign exchange and other ga ins (losses) 1,615 (7,892) 7,685 (8,526) Total other expenses (3,217) (12,723) (11,642) (27,850) Income before income taxes 9,929 4,157 18,912 36,560 Less : income tax expense (benefi t) (378) (118) 15 (104) Add: interest in income of equity method investments 2,836 5,252 7,748 5,098 Net income 12,387 9,527 26,645 41,762 Gain from repurchase of preference shares 3,830 38,195 90,998 38,195 Net income available to Maiden common shareholders $ 16,217 $ 47,722 $ 117,643 $ 79,957 Basic and diluted earnings per share attributable to Maiden common shareholders $ 0.19 $ 0.56 $ 1.35 $ 0.93 Annualized return on average common equity (3) 29.2% 183.8% 65.6% 90.7% 2021 2020 Maiden Holdings, Ltd. Consolidated Statements of Income (in thousands (000's), except per share data) For the Three Months Ended December 31, For the Year Ended December 31, 2021 2020
Non-GAAP Financial Measures 11 $ 2,346 $ 45,035 $ 60,481 $ 47,076 $ 0.03 $ 0.53 $ 0.70 $ 0.55 $ (0.27) $ (0.22) $ (0.59) $ (0.15) 3.4% 99.1% 25.0% 25.9% Net income available to Maiden common shareholders $ 16,217 $ 47,722 $ 117,643 $ 79,957 Add (subtract) Net realized losses (gains) on investment (4,635) (273) (12,648) (24,473) Total other-than-temporary impairment losses - - - 2,468 Foreign exchange and other (gains) losses (1,615) 7,892 (7,685) 8,526 Interest in loss (income) of equity method investments (2,836) (5,252) (7,748) (5,098) Change in deferred gain on retroactive reinsurance (4,785) (5,054) (29,081) (14,304) Non-GAAP operating earnings(2) $ 2,346 $ 45,035 $ 60,481 $ 47,076 Weighted average number of common shares - basic 86,457,797 84,786,168 86,068,278 84,333,514 Adjusted weighted average number of common shares and assumed conversions - diluted 86,462,134 84,786,168 86,072,667 84,333,655 Diluted earnings per share attributable to Maiden common shareholders $ 0.19 $ 0.56 $ 1.35 $ 0.93 Add (subtract) Net realized losses (gains) on investment (0.05) (0.00) (0.14) (0.29) Total other-than-temporary impairment losses - - - 0.03 Foreign exchange and other (gains) losses (0.02) 0.09 (0.09) 0.11 Interest in loss (income) of equity method investments (0.03) (0.06) (0.09) (0.06) Change in deferred gain on retroactive reinsurance (0.06) (0.06) (0.33) (0.17) $ 0.03 $ 0.53 $ 0.70 $ 0.55 2021 2020 Non-GAAP operating earnings (2) Non-GAAP diluted operating earnings per common share attributable to Maiden shareholders Annualized non-GAAP operating return on average adjusted common equity(4) Reconciliation of diluted earnings per share attributable to Maiden common shareholders to non- GAAP diluted operating earnings per share attributable to Maiden common shareholders: Reconciliation of net income available to Maiden common shareholders to non-GAAP operating earnings: Non-GAAP diluted operating earnings per share attributable to Maiden common shareholders(2) Non-GAAP basic and diluted operating earnings per share attributable to Maiden common shareholders 2021 2020 For the Year Ended December 31, Maiden Holdings, Ltd. Non - GAAP Financial Measures (in thousands (000's), except per share data) For the Three Months Ended December 31,
Non-GAAP Financial Measures 12 Non-GAAP underwriting results: Gross premiums written $ 3,073 $ 11,156 $ 10,938 $ 31,389 Net premiums written $ 2,885 $ 10,939 $ 10,403 $ 28,432 Net premiums earned $ 12,887 $ 29,253 $ 52,993 $ 106,081 Other insurance revenue 121 357 1,067 1,276 Non-GAAP net loss and LAE(5) (4,546) (5,694) (36,388) (56,103) Commissions and other acquisition expenses (5,686) (9,018) (24,840) (38,796) General and administrative expenses (6) (2,366) (2,370) (10,341) (9,488) Non-GAAP underwriting (loss) income(5) $ 410 $ 12,528 $ (17,509) $ 2,970 Non-GAAP net loss and LAE ratio(7) 34.9% 19.2% 67.3% 52.3% Commission and other acquisition expense ratio (8) 43.7% 30.5% 46.0% 36.1% General and administrative expense ratio(9) 49.7% 44.4% 66.6% 36.4% Expense ratio(10) 93.4% 74.9% 112.6% 72.5% Non-GAAP combined ratio(11) 128.3% 94.1% 179.9% 124.8% Non-GAAP net loss and LAE: Net loss and LAE $ (239) $ 640 $ 7,307 $ 41,799 Less: Change in deferred gain on retroactive reinsurance (4,785) (5,054) (29,081) (14,304) Non-GAAP net loss and LAE(5) $ 4,546 $ 5,694 $ 36,388 $ 56,103 Combined ratio 91.6% 77.1% 126.1% 111.4% Less: Unamortized deferred gain on retroactive reinsurance -36.7% -17.1% -53.9% -13.3% Non-GAAP combined ratio(11) 128.3% 94.2% 180.0% 124.7% Ratios: 2021 2020 Reconciliation of GAAP combined ratio to Non-GAAP combined ratio: 2021 2020 For the Year Ended December 31, Maiden Holdings, Ltd. Non - GAAP Financial Measures (in thousands (000's), except per share data) For the Three Months Ended December 31,
Non-GAAP Financial Measures 13 Investable assets: Total investments $ 822,612 $ 1,320,307 Cash and cash equivalents 26,668 74,040 Restricted cash and cash equivalents 39,419 61,786 Loan to related party 167,975 167,975 Funds withheld receivable 636,412 654,805 Total investable assets (12) $ 1,693,086 $ 2,278,913 Capital: Preference shares $ 159,210 $ 394,310 Common shareholders' equity 225,047 133,506 Total shareholders' equity 384,257 527,816 2016 Senior Notes 110,000 110,000 2013 Senior Notes 152,500 152,500 Total capital resources(13) $ 646,757 $ 790,316 Total Shareholders ’ Equity $ 384,257 $ 527,816 LP Investment Adjustment 4,083 - Unamortized deferred gain on retroactive reinsurance 45,860 74,941 Adjusted shareholders' equity(14) $ 434,200 $ 602,757 Book value per common share $ 2.60 $ 1.57 LP Investment Adjustment 0.05 - Unamortized deferred gain on retroactive reinsurance 0.53 0.89 Adjusted book value per common share (14) $ 3.18 $ 2.46 Reconciliation of total shareholders' equity to adjusted shareholders' equity: Reconciliation of book value per common share to adjusted book value per common December 31, 2021 December 31, 2020 Maiden Holdings, Ltd. Non - GAAP Financial Measures (in thousands (000's), except per share data)
Non-GAAP Financial Measures 14 (3) Return on average common equity is a non-GAAP financial measure. Management uses return on average common equity as a measure of profitability that focuses on the return to common shareholders. It is calculated using net income available to Maiden common shareholders divided by average common shareholders' equity. (1) Book value per common share is calculated using common shareholders’ equity (shareholders' equity excluding the aggregate liquidation value of our preference shares) divided by the number of common shares outstanding. Management uses growth in this metric as a prime measure of the value we are generating for our common shareholders, because management believes that growth in this metric ultimately results in growth in the Company’s common share price. This metric is impacted by the Company’s net income and external factors, such as interest rates, which can drive changes in unrealized gains or losses on our investment portfolio, as well as share repurchases. (4) Non-GAAP operating return on average common equity is a non-GAAP financial measure. Management uses non-GAAP operating return on average adjusted common shareholders' equity as a measure of profitability that focuses on the return to common shareholders. It is calculated using non-GAAP operating earnings divided by average adjusted common shareholders' equity. (2) Non-GAAP operating earnings and non-GAAP basic and diluted operating earnings per common share are non-GAAP financial measure defined by the Company as net income excluding realized investment gains and losses, total other-than-temporary impairment losses, foreign exchange and other gains and losses, interest in income of equity method investments and the change in deferred gain on retroactive reinsurance and should not be considered as an alternative to net income (loss). The Company's management believes that the use of non-GAAP operating earnings and non-GAAP diluted operating earnings per common share enables investors and other users of the Company’s financial information to analyze its performance in a manner similar to how management analyzes performance. Management also believes that these measures generally follow industry practice therefore allowing the users of financial information to compare the Company’s performance with its industry peer group, and that the equity analysts and certain rating agencies which follow the Company, and the insurance industry as a whole, generally exclude these items from their analyses for the same reasons. Non-GAAP operating earnings should not be viewed as a substitute for U.S. GAAP net income.
Non-GAAP Financial Measures 15 (5) Non-GAAP net loss and LAE and Non-GAAP underwriting income (loss): Management has further adjusted the net loss and LAE and underwriting income (loss) by recognizing into income the unamortized deferred gain arising from the LPT/ADC Agreement relating to losses subject to that agreement. The deferred gain represents amounts estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement on Maiden's underwriting income (loss). Management believes reflecting the economic benefit of this retroactive reinsurance agreement is helpful for understanding future trends in our operations. (6) Underwriting related general and administrative expenses is a non-GAAP measure and includes expenses which are segregated for analytical purposes as a component of underwriting loss. (7) Calculated by dividing Non-GAAP net loss and loss adjustment expenses by the sum of net premiums earned and other insurance revenue. (8) Calculated by dividing commission and other acquisition expenses by the sum of net premiums earned and other insurance revenue. (9) Calculated by dividing general and administrative expenses by the sum of net premiums earned and other insurance revenue. (13) Total capital resources is the sum of the Company's principal amount of debt and shareholders' equity. (10) Calculated by adding together the commission and other acquisition expense ratio and general and administrative expense ratio. (11) Calculated by adding together the non-GAAP net loss and loss adjustment expense ratio and expense ratio. (12) Investable assets is the total of the Company's investments, cash and cash equivalents, loan to a related party and funds withheld
Non-GAAP Financial Measures 16 (16) Underwriting income is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities. For purposes of these non-GAAP operating measures, the fee-generating business which is included in our Diversified Reinsurance segment, is considered part of the underwriting operations of the Company. Management believes that this measure is important in evaluating the underwriting performance of the Company and its segments. This measure is also a useful tool to measure the profitability of the Company separately from the investment results and is also a widely used performance indicator in the insurance industry. (15) Alternative investments is the total of the Company’s investment in equity securities, equity method investments and other investments. (14) Adjusted Total Shareholders' Equity and Adjusted Book Value per Common Share: Management has adjusted GAAP shareholders' equity by adding the following items: 1) the unamortized deferred gain on retroactive reinsurance arising from LPT/ADC Agreement; and 2) an adjustment which reflects the equity method accounting related to the fair value of certain hedged liabilities within an equity method investment in a limited partnership held by the Company wherein the ultimate realizable value of the asset supporting the hedged liabilities cannot currently be recognized at fair value. As a result, by virtue of this adjustment, management has also computed the Adjusted Book Value per Common Share. The deferred gain on retroactive reinsurance represents amounts estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement. The LP Investment Adjustment reflects the fair value of the assets not presently able to be recognized currently. We believe reflecting the economic benefit of both items is helpful to understand future trends in our operations, which will improve the Company's shareholders' equity over the settlement or contract periods, respectively.